Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?

被引：10
|
作者：
Moreau, Philippe [1 ]
Rajkumar, S. Vincent [2 ]
机构：
[1] Univ Hosp Hotel Dieu, F-44093 Nantes, France
[2] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
来源：
LEUKEMIA RESEARCH | 2012年 / 36卷 / 06期
关键词：
HIGH-DOSE THERAPY; STANDARD CHEMOTHERAPY; RANDOMIZED-TRIAL; DEXAMETHASONE; THALIDOMIDE; BORTEZOMIB; CONSOLIDATION; RESCUE;
D O I：
10.1016/j.leukres.2012.02.023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：677 / 681
页数：5
相关论文
共 50 条
  • [1] Frontline treatment in multiple myeloma patients not eligible for stem-cell transplantation
    Facon, Thierry
    Darre, Stephane
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) : 737 - 746
  • [2] Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers
    Mohty, Mohamad
    Harousseau, Jean-Luc
    HAEMATOLOGICA, 2014, 99 (03) : 408 - 416
  • [3] Initial treatment of transplant-eligible patients in multiple myeloma
    Rosinol, Laura
    Kumar, Shaji
    Moreau, Phillipe
    Cavo, Michele
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (01) : 43 - 53
  • [4] No Role for Tandem Autologous Stem Cell Transplantation in Modern Treatment Paradigms for Transplant Eligible Multiple Myeloma
    Baljevic, Muhamed
    Biltibo, Eden Ayele
    Dholaria, Bhagirathbhai
    Sengsayadeth, Salyka
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (09): : 829 - 831
  • [5] Autologous Stem-Cell Transplantation for Multiple Myeloma
    Louw, Vernon J.
    Louw, Hymne
    Webb, Michael J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (11): : 1118 - 1119
  • [6] Second Autologous Hematopoietic Stem Cell Transplant as Salvage Therapy for Relapsed Multiple Myeloma: A Global Treatment Option for Eligible Patients
    Gonsalves, Wilson I.
    Kansagra, Ankit
    ACTA HAEMATOLOGICA, 2018, 139 (01) : 45 - 46
  • [7] TREATMENT OF MULTIPLE MYELOMA IN PATIENTS ELIGIBLE FOR THE AUTOLOGOUS STEM CELL TRANSPLANTATION: MATTER OF CHOICE, RESPONSE AND EFFICACY
    Bila, J.
    Jelicic, J.
    Djurasinovic, V.
    Antic, D.
    Todorovic, M.
    Vujic, D.
    Sefer, D.
    Kraguljac, N.
    Bogunovic, M.
    Andjelic, B.
    Vukovic, V.
    Sretenovic, A.
    Gotic, M.
    Elezovic, I.
    Tomin, D.
    Mihaljevic, B.
    HAEMATOLOGICA, 2014, 99 : 654 - 655
  • [8] Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma
    Harousseau, Jean-Luc
    Moreau, Philippe
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (25): : 2645 - 2654
  • [9] Role of autologous stem-cell transplantation in multiple myeloma
    Attal, Michel
    Harousseau, Jean-Luc
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) : 747 - 759
  • [10] COST-EFFECTIVENESS ANALYSIS OF STRATEGIES OF AUTOLOGOUS STEM-CELL TRANSPLANTATION AND MAINTENANCE THERAPY FOR TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA IN CHINA
    Wu, W.
    Lou, Y.
    Fan, X.
    Ding, S.
    Zhou, Y.
    Keramat, S. A.
    Yang, W.
    Tang, F.
    Comans, T.
    Dong, H.
    VALUE IN HEALTH, 2023, 26 (12) : S195 - S195
12345